Overview of Ametil

Property	Description
Active ingredient	Prochlorperazine
Form	Tablet, Suppository, Injectable solution, Syrup
Pharmacological class	Phenothiazine derivative, Neuroleptic
Common use	Control of severe nausea and vomiting
Origin	Synthetic compound

What Type of Medicine is Ametil? (Identity and Classification)

Ametil is a synthetic, prescription-only medication containing the active ingredient Prochlorperazine, which belongs to the potent phenothiazine derivative family. This formulation, characterized by its piperazine side chain, is specifically engineered for enhanced anti-emetic action compared to certain earlier phenothiazines. Pharmacologically, it is classified as a First-Generation Antipsychotic (FGA), a type of neuroleptic, exerting a centralized effect on the nervous system. The International Nonproprietary Name (INN) Prochlorperazine is recognized for its global clinical importance.

Composition and Available Forms of Ametil (Preparation Details)

The core therapeutic component is Prochlorperazine, supplied as a single agent, typically as the maleate or mesilate salt. A distinctive feature of Ametil preparations is the availability of multiple dosage forms—including oral tablets and syrups, rectal suppositories, and sterile injectable solutions in ampoules. This breadth of formats allows for administration via oral, rectal, or parenteral (intramuscular and intravenous) routes, which is vital when a patient's condition makes oral intake impossible. This chemical identity is classified as a piperazine phenothiazine.

What is the General Purpose of Prochlorperazine? (High-Level Utility)

The general purpose of Prochlorperazine is the control of severe nausea, vomiting, and certain symptoms associated with balance disturbances. Its anti-emetic action is rooted in its role as a potent dopamine receptor antagonist, primarily achieving its effect by blocking receptors located in the brain's chemoreceptor trigger zone (CTZ). This mechanism ensures that signals that would normally trigger the vomiting reflex are suppressed. Furthermore, its influence on the vestibular system contributes to its utility in stabilizing balance to help manage vertigo.

Regulatory References

U.S. National Library of Medicine

What side effects are possible with Ametil?

Possible side effects and safety information

The safety profile of Prochlorperazine (Ametil), a phenothiazine derivative, is characterized by potential adverse reactions organized by frequency and physiological system involvement, as documented in official government labeling.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by regulatory agencies based on their documented occurrence rates:

Very Common: Drowsiness and Sedation are frequently reported.
Common: Extrapyramidal Symptoms (EPS), such as Akathisia and Acute Dystonia, may appear, alongside Anticholinergic effects like dry mouth and blurred vision, as well as Orthostatic Hypotension (dizziness upon standing).
Rare: Documented rare adverse events include Cholestatic Jaundice and severe Blood Dyscrasias, such as Agranulocytosis.

Serious Adverse Reactions and Safety Constraints

Certain risks are officially classified as serious and require specific attention, particularly within the Nervous System and Cardiovascular System Disorders:

Neurological Risks: The official labeling highlights the risk of Tardive Dyskinesia (TD), a potentially irreversible movement disorder associated with long-term exposure. The rare, potentially fatal complex of Neuroleptic Malignant Syndrome (NMS) is also documented.
Cardiac Risks: Prochlorperazine carries a risk for QT interval prolongation, which may lead to serious ventricular arrhythmias, including sudden cardiac death.
Population Constraints: Regulatory documents state that Prochlorperazine is not approved for the treatment of dementia-related psychosis in older adults due to a documented increase in mortality risk in this patient population. Use in patients with severe Central Nervous System (CNS) depression is also constrained.

Time- and Duration-Related Safety Patterns

Acute neurological effects, such as Dystonia and Akathisia, are noted to be more likely to occur early in the course of treatment or during dose adjustments. Conversely, the risk of Tardive Dyskinesia is associated with prolonged exposure to the medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

Suspected overdose with Ametil (Prochlorperazine) requires the immediate seeking of medical attention as officially mandated by regulatory authorities. The official overdose profile is defined by specific, life-threatening clinical manifestations and the need for specialized supportive care, given that no specific antidote is known.

Documented Manifestations

Overdose presentations primarily involve the Central Nervous System (CNS), ranging from profound somnolence, lethargy, and altered mental status to coma. Other documented signs include severe Extrapyramidal Symptoms (EPS) such as muscle rigidity, tremor, and potentially convulsions or seizures. Cardiovascular signs include severe hypotension, tachycardia, and cardiac dysrhythmias.

Severe Outcomes and Emergency Actions

The official labeling highlights the potential for Neuroleptic Malignant Syndrome (NMS), a potentially fatal syndrome requiring immediate discontinuation of the drug upon diagnosis. Overdose may lead to life-threatening heart rhythm disturbances and sudden death.

Management is limited to intensive symptomatic treatment and continuous medical monitoring. Specific supportive measures include the use of activated charcoal and the careful management of hypotension with agents such as norepinephrine or phenylephrine, with official guidance advising against the use of epinephrine. Furthermore, regulatory notes indicate that neonates whose mothers received phenothiazines may require intensive care due to documented effects like extrapyramidal signs.

Therapeutic Uses of Ametil

Quick Facts: Uses of Ametil

Addresses: Symptoms associated with depression in adults.
Investigated for: Managing symptoms of chronic pain syndromes.
Role: May support relief of certain mood-related symptoms.

Ametil is prescribed for the management of depressive symptoms in adult patients. The therapeutic goal is to help support the patient's overall emotional state and assist in the management of specific manifestations associated with depression.

Beyond this primary indication, the compound is studied for its potential role in addressing symptoms linked to various chronic pain conditions. This includes the potential management of discomfort associated with conditions such as diabetic neuropathy, fibromyalgia, and certain forms of headache.

The medication may also be used to address related concerns, including chronic pelvic pain (interstitial cystitis) and disturbances in sleep patterns, although these uses are generally considered off-label. A healthcare professional can evaluate the suitability of this medication for an individual’s specific condition.

Eligibility and Restrictions for Use

The official regulatory profile for Ametil (Prochlorperazine) defines eligibility by specific population criteria and contraindications listed in government-approved labeling.

Eligibility and Exclusion Status

Status	Population or Condition	Regulatory Basis
Allowed Use	Adults; Children aged 2 years and older and weighing 20 lbs (9 kg) or more.	Standard Labeled Condition
Contraindicated	Known hypersensitivity to phenothiazines; Comatose states; Presence of large amounts of CNS depressants; Children under 2 years or 20 lbs.	Absolute Prohibition
Restricted Use	Older adults; Patients with severe cardiovascular disorders; Pregnancy (3rd trimester); Lactation; Blood dyscrasias.	Caution/Not Recommended

Eligibility is officially prohibited in children with signs suggesting Reye's syndrome and in all patients with dementia-related psychosis, a condition for which Ametil is not approved. Caution is required for older adults, often necessitating a lower initial dose due to increased sensitivity and potential for decreased organ function. Use during the third trimester of pregnancy is not recommended due to the risk of extrapyramidal or withdrawal symptoms in the newborn, as documented in regulatory guidelines. The official label dictates these specific population-based boundaries for use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details interaction patterns for Ametil (Prochlorperazine) as described in official government regulatory documents, focusing on established risk classifications and required management strategies.

Category	Official Interaction Statement
Contraindicated Combinations	Co-administration is formally prohibited with certain medications known to prolong the QT interval, including Pimozide, Thioridazine, and Dofetilide, due to the documented risk of severe ventricular arrhythmia. The use of this medicine is also contraindicated in comatose states or in the presence of large amounts of general CNS Depressants, such as alcohol and certain narcotics.
Pharmacodynamic Enhancement	Combining Prochlorperazine with other CNS Depressants results in a recognized intensification or prolongation of the central depressive action, leading to augmented sedation. The concurrent use of Anticholinergic Agents (e.g., specific tricyclic antidepressants) may also potentiate significant additive anticholinergic effects. Furthermore, the co-use of Antihypertensive Drugs may result in an enhanced hypotensive effect.
Exposure Modification & Timing	Oral forms of Prochlorperazine may experience reduced absorption and decreased plasma concentration when administered simultaneously with Antacids (containing aluminum or magnesium) or Oral Iron Salts. To prevent this pharmacokinetic interaction, official labeling requires these agents to be administered with a separation of two to three hours from Prochlorperazine dosing.

The regulatory profile restricts the use of Epinephrine to treat Prochlorperazine-induced low blood pressure, as this combination may paradoxically lower blood pressure further. Elderly patients are officially noted as having heightened sensitivity to certain pharmacodynamic interaction outcomes, such as fall risk due to somnolence and anticholinergic effects.

Mechanism of Action

Ametil, a phenothiazine derivative, functions primarily as a central nervous system neurotransmitter receptor antagonist. Its primary molecular target is the Dopamine D2 receptor ( D2), where it exerts an inhibitory effect. This D2 receptor antagonism is particularly relevant in the chemoreceptor trigger zone, which leads to reduced dopaminergic signaling.

Additionally, the compound interacts with several other receptors. It acts as an antagonist at Histamine H1 receptors ( H1) and exhibits affinity for Muscarinic cholinergic receptors ( mAChR) and Alpha-1 adrenergic receptors (alpha1). The H1 and alpha1 blockade contributes to modulation of central and peripheral nerve activity.

The composite receptor antagonism results in the functional depression of certain neural pathways, including those in the brainstem and limbic system, leading to a system-level decrease in signal transmission within these circuits and an overall reduction in central nervous system excitability.

Dosage and Administration Information

Official Administration Guidelines for Ametil

The usage of Prochlorperazine (Ametil) is defined by its approved dosage forms and strict administration parameters, which vary by therapeutic setting and patient population. The medicine is available for oral intake (tablets, extended-release capsules, and syrup), rectal insertion (suppositories), and parenteral administration via intramuscular (IM) or intravenous (IV) injection.

For severe nausea and vomiting, the standard oral dose is typically 5 mg or 10 mg, 3 to 4 times daily, with a maximum daily dose of 40 mg. In contrast, the maintenance dosing for psychotic disorders can range up to 150 mg daily and requires gradual dose increases (titration) every 2 to 3 days to establish control. Use for non-psychotic anxiety is restricted to a maximum of 12 weeks total duration and a dose not exceeding 20 mg per day.

Procedural and Population-Specific Requirements

Category	Official Instructions and Entities
Route of administration	Oral, Rectal, Intramuscular (IM), Intravenous (IV).
Age-group administration rules	Not recommended for children under 2 years of age or under 9 kg (20 lbs). Older adults require a lower initial dose that is increased more gradually.
Special procedural conditions	IV injection must be administered slowly at a rate not exceeding 5 mg per minute. After any parenteral (IM/IV) administration, the patient should remain recumbent and observed for at least 30 minutes.
Frequency pattern	Multiple times per day (3–4 times daily), Twice daily, or As-needed (PRN) for acute IM use.

These official instructions establish the precise parameters for administering Prochlorperazine, dictating the route based on clinical need, mandating maximum dosage limits for specific uses, and defining necessary procedural techniques (e.g., slow IV rate) and observation periods following injectable administration. The requirements for dose adjustments in older patients and children under 2 years set clear boundaries for use in vulnerable groups.

Recent Clinical Evidence

Research evidence / Overview of Studies for Ametil (Prochlorperazine)

Evidence for Use in Acute Nausea, Vomiting, and Balance Disturbances

Research was studied for control of severe nausea and vomiting, which are conditions associated with acute or disruptive episodes. Studies for this indication primarily involve short-term, randomized controlled trials (RCTs) and research involving comparator groups. These studies were conducted in settings with varying symptom burdens, and research explored how outcomes related to physical discomfort evolved over short, defined time intervals. Studies monitored outcomes such as patient-reported nausea intensity and the frequency of vomiting episodes.

For this acute use, findings describe patterns observed in the studies over very short observational periods, typically measured in minutes to a few hours post-administration. This body of evidence contributes to the broader evidence landscape related to its use for this specific, acute purpose. The follow-up durations were limited, and the research does not typically examine profiles for individuals requiring continuous, non-acute studies observing anti-emetic patterns.

Evidence for Use in Specific Psychiatric Conditions

Older clinical trials and systematic reviews have examined the profile of Ametil as a class of medication studied in these contexts. Studies were evaluated in adult populations with specific psychotic disorders, with some evidence also relevant in trials assessing short-term or episodic symptom patterns of generalized non-psychotic anxiety. Studies monitored outcomes reflecting daily functioning or activity level, using standardized scales to track how symptoms evolved in the observed populations.

For its use in anxiety, research exploring short-term symptom changes was conducted, with follow-up periods generally measured in weeks. Findings indicate patterns related to symptom changes over these specific, limited time intervals. The existing long-term data for its use in psychotic disorders is often viewed within the context of older research.

What Remains Uncertain in the Research Landscape

Across many applications, there is limited information for long-term outcomes. The data for certain groups remain limited, and the sample sizes were modest for certain subgroups defined by specific comorbidities. For other areas explored, such as chronic pain and depressive symptoms, the evidence is primarily observational. Evidence quality varies across studies, and the certainty remains low for establishing a clear primary therapeutic role in these non-core areas. The results apply only to the populations studied and do not provide insight into its use for anxiety secondary to other chronic conditions.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Ametil (FAQ)

Q: How quickly should I expect to notice the effects of Ametil?

Official product information indicates that the effects are often noticed quickly. The onset of action is typically observed within about 30 to 40 minutes following oral administration, and within 10 to 20 minutes following an intramuscular injection.

Q: Does Ametil need to be taken indefinitely?

Regulatory information shows that for the short-term treatment of non-psychotic anxiety, use is generally limited to a maximum of 12 weeks. For chronic conditions such as schizophrenia, the drug is used in contexts where long-term management may be necessary.

Q: Why do some people refer to Ametil as a 'mood stabilizer'?

Ametil is officially classified as a phenothiazine derivative and a First-Generation Antipsychotic (or neuroleptic) agent. This is the official designation described in regulatory documents.

Q: What types of supplements are known to interact with Ametil?

Regulatory documents advise that there is insufficient information to confirm the safety of complementary medicines, herbal remedies, and supplements when taken with Ametil. Regulatory agencies advise disclosing all supplements to a healthcare provider as a general precaution.

Q: What is the typical timeframe for Ametil to reach its full therapeutic effect?

For repeated oral dosing, the concentration of the drug in the body typically reaches a stable level, known as steady state, by approximately seven days. Reaching this steady state is a factor in achieving the full desired therapeutic effect.

Q: Does Ametil have a black box warning?

Yes, the official drug label includes a BOXED WARNING. This warning highlights the risk of increased mortality in older adults with dementia-related psychosis, a condition for which Ametil is not approved.

Q: Is Ametil a painkiller?

Ametil is officially classified as an anti-emetic (to control severe nausea and vomiting) and an antipsychotic. It is not listed as an analgesic, or painkiller, in its regulatory indications.

Q: How long do the common side effects of Ametil typically last?

Acute neurological side effects, such as a movement disorder known as Dystonia, usually lessen within a few hours. According to official documents, these acute effects are reported to subside within 24 to 48 hours after discontinuation of the drug.

Q: Can I take Ametil with common over-the-counter cold medicines?

Taking Ametil with any medicine that acts as a central nervous system (CNS) depressant can intensify feelings of sedation and drowsiness. Many cold and flu medicines, especially those containing alcohol or certain strong antihistamines, are classified as CNS depressants.

Q: Does Ametil cure the condition, or just manage symptoms?

The official indications state that the drug is used for the control of severe nausea and vomiting and the treatment of symptoms of schizophrenia and anxiety. This indicates a role in symptomatic management for the approved uses.

Q: Is weight gain a common side effect of Ametil?

Reports indicate that increased appetite and weight gain have been reported as side effects in patient information sources. Changes in weight or appetite are aspects of treatment that can be discussed with a healthcare provider.

Q: What should I do if I forget to take a dose of Ametil?

Instructions for managing a missed dose are outlined in the official patient information. Specific guidance on how and when to skip or resume a dose should be followed as directed by a healthcare professional.

Q: Can people with liver problems use Ametil?

Official labeling advises that the drug should be avoided in children and adolescents whose symptoms suggest Reye's syndrome due to its potential to affect the liver. General guidance regarding the drug's use in chronic liver impairment in adults is not explicitly detailed in the core regulatory documents.

Q: How long does Ametil stay in the body after the last dose?

Studies of the drug's absorption show that the terminal elimination half-life (the time it takes for the concentration to reduce by half) is approximately 8 to 9 hours after a single dose.

Q: Do the effects of Ametil build up over time?

Official clinical pharmacology studies indicate that when taken orally on a regular schedule, the drug and its metabolite resulted in an accumulation until a stable concentration was achieved in the body.

Q: Is Ametil addictive?

Ametil (Prochlorperazine) is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA).

Q: What if I feel better and want to stop taking Ametil?

Abruptly stopping Ametil, especially after long-term use, may cause withdrawal symptoms such as nausea, vomiting, or trouble sleeping. Official patient guidance indicates that the process of stopping the medicine may involve gradually reducing the amount over time.

Q: Does the appearance of Ametil tablets vary by manufacturer?

The official package insert describes the characteristics of the brand tablets containing Prochlorperazine maleate. However, the appearance (shape, color, imprint) of generic versions is expected to vary by manufacturer and should be verified against the specific packaging.

Q: Is Ametil known to cause mood swings?

The official labeling reports side effects related to mental state, such as agitation and insomnia (trouble sleeping). These effects relate to the drug's activity on the central nervous system.

Q: Is it safe to use Ametil while undergoing surgery?

It is important to inform your healthcare provider if you are scheduled for a procedure like a myelogram (spinal x-ray). Official information regarding a myelogram notes the drug is typically discontinued two days before and one day after the procedure.

Q: Is Ametil considered a controlled substance?

Ametil (Prochlorperazine) is not scheduled as a controlled substance under the U.S. Controlled Substances Act.

Q: Can Ametil be crushed or chewed if a person has trouble swallowing?

Standard tablets are typically swallowed whole. However, certain specialized forms, like buccal tablets, are designed to dissolve slowly against the gum, and it is important that these are not swallowed whole or chewed. Liquid and injectable forms are also available.

Q: Are there any potential problems with taking Ametil on an empty stomach?

Official patient instructions state that standard tablets can generally be taken with or without food. However, specialized forms, such as buccal tablets, are advised to be taken after meals to allow them the necessary time to dissolve properly.

Q: What should I know about using Ametil near the expiration date?

Patient safety guidance advises that medicine that is outdated or no longer needed should not be kept. If the expiration date is near, it is advised to seek guidance on proper disposal methods from a healthcare professional.

Q: Is Ametil available as a generic version?

Yes. The active ingredient, Prochlorperazine maleate, is widely available as a generic formulation.

Q: Is Ametil known to interact with herbal remedies like St. John’s Wort?

Regulatory documents state there is not enough information to confirm that specific herbal remedies, like St. John's Wort, are safe to take with Ametil. Combination use requires professional consideration.

How should Ametil be stored and disposed of?

How to Store and Dispose of Ametil?

The official storage and disposal instructions specific to the product Ametil are not available in the authoritative government regulatory documents searched (including those from the FDA and EMA). For proper use and to ensure medication stability, it is essential to follow the specific instructions printed on the product labeling or packaging provided by the manufacturer.

In the absence of product-specific guidelines, general regulatory advice for medicine management includes:

Storage: Store the medicine out of sight and reach of children and pets to prevent accidental ingestion or poisoning. Keep it in a safe, locked location.
Disposal: The preferred method for disposing of most unused or expired prescription and over-the-counter medicines is a drug take-back program or a mail-back envelope. If these options are not readily available, check the official regulatory flush list for certain high-risk medicines; otherwise, dispose of the medicine in the household trash after mixing it with an unappealing substance and sealing it in a container.

Consult a pharmacist or healthcare professional for the most accurate storage and disposal guidance for Ametil.

Ametil